Your search returned 530 results.

Results
	61.	Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update. [electronic resource] by Nijhof, Inger S van de Donk, Niels W C J Zweegman, Sonja Lokhorst, Henk M Producer: 20181119 In: Drugs vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	62.	Clinical development of panobinostat in classical Hodgkin's lymphoma. [electronic resource] by Oki, Yasuhiro Copeland, Amanda Younes, Anas Producer: 20111011 In: Expert review of hematology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	63.	[Inhibitory effect of histone deacetylase inhibitor LBH589 on multiple myeloma MM1R cells in vitro]. [electronic resource] by Zhang, Ling Ma, Yan-Ping Jia, Gu Lu, Yu-Jin Zhang, Li Lu, Hong Chang, Ming-Xing Producer: 20131205 In: Zhongguo shi yan xue ye xue za zhi vol. 20 Availability: No items available. Save to lists Add to cart (remove)
	64.	A phase I study of panobinostat in combination with ICE (Ifosfamide, Carboplatin and Etoposide) in patients with relapsed or refractory classical Hodgkin lymphoma (cHL). [electronic resource] Producer: 20150212 In: Clinical advances in hematology & oncology : H&O vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	65.	Extended follow-up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi-centre phase I/II Clinical Trial). [electronic resource] by Popat, Rakesh Brown, Sarah R Flanagan, Louise Hall, Andrew Gregory, Walter Kishore, Bhuvan Streetly, Matthew Oakervee, Heather Yong, Kwee Cook, Gordon Low, Eric Cavenagh, Jamie Producer: 20200504 In: British journal of haematology vol. 185 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	66.	Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine. [electronic resource] by Suresh, P S Devaraj, V C Srinivas, Nuggehally R Mullangi, Ramesh Producer: 20170118 In: Biomedical chromatography : BMC vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	67.	Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat. [electronic resource] by Becher, Isabelle Werner, Thilo Doce, Carola Zaal, Esther A Tögel, Ina Khan, Crystal A Rueger, Anne Muelbaier, Marcel Salzer, Elsa Berkers, Celia R Fitzpatrick, Paul F Bantscheff, Marcus Savitski, Mikhail M Producer: 20170515 In: Nature chemical biology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	68.	Clinical Pharmacokinetics and Pharmacodynamics of Panobinostat. [electronic resource] by Van Veggel, Mathilde Westerman, Elsbeth Hamberg, Paul Producer: 20190503 In: Clinical pharmacokinetics vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	69.	Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between HDAC2 and HDAC8. [electronic resource] by Stoddard, Shana V May, Xavier A Rivas, Fatima Dodson, Kyra Vijayan, Sajith Adhika, Swetha Parker, Kordarius Watkins, Davita L Producer: 20190529 In: Molecular informatics vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	70.	Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib. [electronic resource] by Wilson, Andrew J Sarfo-Kantanka, Kofi Barrack, Toby Steck, Alexandra Saskowski, Jeanette Crispens, Marta A Khabele, Dineo Producer: 20170512 In: Gynecologic oncology vol. 143 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	71.	Effective use of panobinostat in combination with other active agents in myeloma in a novel five-drug combination: Case report and interesting observations. [electronic resource] by Rajan, Archana M Buadi, Francis K Rajkumar, Vincent Producer: 20160602 In: American journal of hematology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	72.	Class I and II Histone Deacetylase Inhibitor LBH589 Promotes Endocrine Differentiation in Bone Marrow Derived Human Mesenchymal Stem Cells and Suppresses Uncontrolled Proliferation. [electronic resource] by Schröder, Christoph Khatri, Rahul Petry, Sebastian Friedrich Linn, Thomas Producer: 20211124 In: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association vol. 129 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	73.	A phase II trial of panobinostat, a histone deacetylase inhibitor, in the treatment of patients with refractory metastatic renal cell carcinoma. [electronic resource] by Hainsworth, John D Infante, Jeffrey R Spigel, David R Arrowsmith, Edward R Boccia, Ralph V Burris, Howard A Producer: 20110906 In: Cancer investigation vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	74.	Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes. [electronic resource] by Jones, Richard Brad O'Connor, Rachel Mueller, Stefanie Foley, Maria Szeto, Gregory L Karel, Dan Lichterfeld, Mathias Kovacs, Colin Ostrowski, Mario A Trocha, Alicja Irvine, Darrell J Walker, Bruce D Producer: 20151221 In: PLoS pathogens vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	75.	Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001. [electronic resource] by Ramakrishnan, Vijay Kimlinger, Teresa Timm, Michael Haug, Jessica Rajkumar, S Vincent Kumar, Shaji Producer: 20150203 In: Leukemia research vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	76.	Panobinostat approved for multiple myeloma. [electronic resource] Producer: 20160602 In: Cancer discovery vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	77.	Naive CD4+ T Cells Harbor a Large Inducible Reservoir of Latent, Replication-competent Human Immunodeficiency Virus Type 1. [electronic resource] by Zerbato, Jennifer M McMahon, Deborah K Sobolewski, Michelle D Mellors, John W Sluis-Cremer, Nicolas Producer: 20200914 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	78.	Therapy sequencing strategies in multiple myeloma: who, what and why? [electronic resource] by Costello, Caitlin Mikhael, Joseph R Producer: 20180808 In: Future oncology (London, England) vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	79.	A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma. [electronic resource] by Ibrahim, Nageatte Buchbinder, Elizabeth I Granter, Scott R Rodig, Scott J Giobbie-Hurder, Anita Becerra, Carla Tsiaras, Argyro Gjini, Evisa Fisher, David E Hodi, F Stephen Producer: 20171116 In: Cancer medicine vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	80.	A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors. [electronic resource] by Fukutomi, Akira Hatake, Kiyohiko Matsui, Kaoru Sakajiri, Sakura Hirashima, Tomonori Tanii, Hiromi Kobayashi, Ken Yamamoto, Nobuyuki Producer: 20120920 In: Investigational new drugs vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 530 results.